• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Boehringer Aims High with Angels Initiative
An innovative scheme to create a community of 1,500 stroke-ready hospitals across Europe has been recognized with the Most Valuable HCP/Healthcare Award at the European arm of theeyeforpharma Awards 2017.The Angel ’s Initiative from Boehringer Ingelheim – which aims to save 100,000 lives by May 2019 – was voted the winner in a unanimous decision by the expert panel of judges.Only one-third of stroke patients in Europe have access to organized stroke care, while just one per cent of stroke patients in emerging markets are provided with lifesaving treatments. In response, the Angels Initiative is working to establish m...
Source: EyeForPharma - April 25, 2017 Category: Pharmaceuticals Authors: Danielle Barron Source Type: news

Janssen to Present the Strength and Promise of its Hematologic Malignancies Portfolio and Pipeline at ASH 2021
RARITAN, N.J., November 4, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that more than 45 company-sponsored abstracts, including 11 oral presentations, plus more than 35 investigator-initiated studies will be featured at the American Society of Hematology (ASH) Annual Meeting and Exposition. ASH is taking place at the Georgia World Congress Center in Atlanta and virtually from December 11-14, 2021.“We are committed to advancing the science and treatment of hematologic malignancies and look forward to presenting the latest research from our robust portfolio and pipeline during ASH...
Source: Johnson and Johnson - November 5, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news